Market Capitalization (Millions $) |
87 |
Shares
Outstanding (Millions) |
17 |
Employees |
24 |
Revenues (TTM) (Millions $) |
62 |
Net Income (TTM) (Millions $) |
-10 |
Cash Flow (TTM) (Millions $) |
-22 |
Capital Exp. (TTM) (Millions $) |
3 |
Prophase Labs Inc
Prophase Labs Inc is a publicly-traded, leading vertically-integrated health and wellness company headquartered in Doylestown, Pennsylvania, USA. The company is engaged in the research, development, manufacture and marketing of over-the-counter (OTC) healthcare and dietary supplements. It operates through two segments: Prophase Laboratories, which focuses on the development of OTC cold remedy products, and Prophase Diagnostics, which specializes in developing and distributing diagnostic test kits.
Prophase Labs began its operations in 1988 and has since then grown to become a significant player in the health and wellness industry. Its flagship product, the Cold-EEZEe brand, a zinc gluconate glycine product, is a top-selling cold remedy in the United States. The company is focused on leveraging its research and development capabilities to create innovative products that address the changing needs of consumers. It does this by researching market trends, monitoring consumer preferences, and identifying emerging health concerns.
Prophase Labs is vertically integrated, with a state-of-the-art manufacturing plant that produces its own products. This enables the company to have greater control over the quality of its products, reduce costs and improve supply chain efficiency. Additionally, the company has a proven track record for achieving regulatory approvals from the US Food and Drug Administration (FDA) for its products.
The company's commitment to innovation is reflected in the significant investment it has made in its research and development (R&D) capabilities. Prophase Labs employs a team of scientists, technicians and quality control personnel who work in its in-house R&D laboratory. This group is responsible for developing new products, reformulations, and improving existing products. The company invests significant resources in R&D to stay ahead of the competition and bring innovative and clinically-proven products to the market.
Apart from its OTC healthcare products, Prophase Labs has also ventured into the distribution of diagnostic test kits through its ProPhase Diagnostics segment. The company distributes a wide range of COVID-19 diagnostic test kits and has partnered with leading manufacturers to provide quality products to its customers.
Prophase Labs is committed to providing high-quality products to its customers while maintaining ethical business practices. The company has a code of conduct for its employees and partners that outlines its values and principles. It also has various sustainability initiatives that aim to minimize its impact on the environment.
In conclusion, Prophase Labs is a leading vertically-integrated health and wellness company that is committed to providing innovative, high-quality products to its customers. With its focus on research and development, vertical integration, and commitment to ethical business practices, the company is well-positioned to continue its growth and success in the dynamic health and wellness industry.
Company Address: 711 Stewart Ave Garden City 11530 NY
Company Phone Number: 345-0919 Stock Exchange / Ticker: NASDAQ PRPH
PRPH is expected to report next financial results on March 28, 2024. |
|
|